image
Lixte Biotechnology Holdings, Inc. LIXT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.62
1.25 %
$ 3.64 M
Market Cap
-0.94
P/E
BALANCE SHEET
4.31 M ASSETS
-22.51%
Growth Rates
1Year -22.51%
3Years -6.25%
5Years -0.13%
7Years 38.83%
10Years 22.68%
314 K LIABILITIES
-20.50%
Growth Rates
1Year -20.50%
3Years 13.17%
5Years 8.27%
7Years 5.30%
10Years -0.25%
3.99 M EQUITY
-22.66%
Growth Rates
1Year -22.66%
3Years -7.28%
5Years -0.64%
7Years 51.83%
10Years 32.68%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Lixte Biotechnology Holdings, Inc.
image
Current Assets 4.31 M
Cash & Short-Term Investments 4.2 M
Receivables 0
Other Current Assets 105 K
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 314 K
Accounts Payable 121 K
Short-Term Debt 0
Other Current Liabilities 193 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005
ASSETS
Cash & Cash Equivalents 4.2 5.4 4.8 5.1 2.6 4.3 1.3 0.2 25.3 K 44.4 K 0.5 1.7 14.3 K 0.1 1.5 10.4 K 0.5 0.7 4.63 K
Short Term Investments 0 0 0 0 0 0 0 0 0.1 0.2 6.14 K 6.13 K 0.4 1.6 25 K 0 0 0 0
Receivables 0 0 0 0 14.4 K 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 60.9 K 0 0 0 0 44.7 K 0 0 0 0 0
Other Current Assets 0.1 0.2 0.3 0.2 93.3 K 0.1 0.1 0.2 0.2 0.3 33.9 K 51.6 K 64.3 K 94.7 K 32.4 K 41.1 K 0.1 70.4 K 0
Total Current Assets 4.3 5.6 5.1 5.2 2.7 4.3 1.4 0.4 0.6 0.5 0.6 1.8 0.4 1.9 1.6 51.5 K 0.6 0.8 4.63 K
PP&E 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 128 742 1.06 K 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0.1 0.2 76.9 K 0 2.29 K 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 (0.1) (0.2) 76.9 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 4.3 5.6 5.1 5.2 2.7 4.3 1.4 0.4 0.6 0.5 0.6 1.8 0.4 1.9 1.6 51.7 K 0.6 0.8 4.63 K
LIABILITIES
Accounts Payable 0.1 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.1 80.4 K 0.1 0.1 0 92.7 K 73.7 K 31.8 K 14.6 K
Short Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 K 0 0 0
Other Current Liabilities 36.2 K 47 K 0 10.5 K 0 0 61 K 0 2 K 92.7 K 0.2 0.2 0.2 92.7 K 0.3 0.2 0.2 92.7 K 2.15 K
Total Current Liabilities 0.3 0.4 0.3 0.2 0.2 0.2 0.4 0.2 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.3 0.1 12.5 K
Long Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 0.3 0.4 0.3 0.2 0.2 0.2 0.4 0.2 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.3 0.1 12.5 K
EQUITY
Common Stock 225 1.66 K 1.37 K 1.24 K 6.7 K 6.7 K 5.8 K 4.79 K 4.79 K 4.55 K 4.16 K 4.16 K 3.53 K 3.51 K 3.05 K 2.79 K 2.78 K 2.66 K 270
Retained Earnings (48.5) (43.4) (37.1) (30.4) (27.1) (24.6) (22.5) (20.7) (18.6) (15.7) (13.0) (11.6) (8.0) (5.9) (5.0) (3.5) (2.2) (0.5) 32.9 K
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Equity 4.0 5.2 4.8 5.0 2.4 4.1 1.0 0.2 0.3 0.3 0.2 1.5 79 K 1.7 1.3 (0.3) 0.4 0.6 7.87 K
Total Liabilities and Equity 4.3 5.6 5.1 5.2 2.7 4.3 1.4 0.4 0.6 0.5 0.6 1.8 0.4 1.9 1.6 51.7 K 0.6 0.8 4.63 K
SHARES OUTSTANDING
Common Shares Outstanding 1.9 0.2 1.3 1.1 1.1 1.0 0.9 0.8 0.8 0.7 0.7 0.6 586.2 578.9 488.6 465.4 445.1 379.2 45.0